ECO Animal Health Group
EAH · AIM · Health Care · mcap £63m · 95.5p 1 open situation →
Timeline · every situation
dots = announcementsOpen · 1
Project milestones◷ in 68 days
ECOVAXXIN MS EU approval and launch
USDA-CVB accepted field safety data; US licence pending
ECOVAXXIN MS was a US and UK approval project, with the USDA accepting the pivotal efficacy study in December 2025. It won EU approval in December 2025, ahead of schedule, and launched in July 2026 with first orders. On 17 Sep 2026 USDA-CVB confirmed the US field safety data fulfils the licensure requirement. US approval is still expected by end of calendar 2026.
- US approval
- expected by end of calendar year 2026
- Other filings
- Thailand and Argentina dossiers submitted after year end 17 Sep 2026 ↗
- Label data
- 44-week duration of immunity data to be submitted for the label in July
- Next milestone
- US marketing approval expected by end of calendar year 2026 17 Sep 2026 ↗
- Field safety data
- USDA-CVB confirmed on 17 Sep 2026 it fulfils the field safety requirements to support licensure 17 Sep 2026 ↗
- Trial size
- More than 170,000 commercial laying pullets across three sites in Michigan, Indiana and Wisconsin 17 Sep 2026 ↗
Next: US marketing approval expected by end of calendar 2026 · 31 Dec 2026
- 17 Sep 2026 USDA-CVB accepted field safety data; US licence pending
- 15 Jul 2026 EU approved and launched; US approval expected
- 2 Jul 2026 EU commercial launch completed in Madrid
- 11 Mar 2026 USDA safety assessment favourable
Closed · 4
Company filings. Not investment advice.